Skip to Content

College of Engineering and Computing

Faculty and Staff

Colin Evans

Title: Assistant Professor
Department: School of Medicine, Biomedical Engineering
College of Engineering and Computing
Office: Building 1. School of Medicine Campus
LinkedIn: My LinkedIn profile
Resources: The Evans Laboratory
My Publications
Research Gate
Colin Evans, headshot


2011: PhD (pass without corrections), Cardiovascular Biology, King’s College London, UK
2006: BSc (1st class honors), Exercise Science, University of Birmingham, UK


Dr. Evans obtained his PhD at King’s College London (2011) and performed postdoctoral training at the University of Cambridge (2011-2017) and Northwestern University (2017-2019). Following his appointment to the research faculty of Northwestern University (2019-2023), Dr. Evans joined the University of South Carolina as Assistant Professor (2023-present). In his current role, Dr. Evans is a lead faculty member of the Department of Cell Biology and Anatomy and the Cardiovascular Translational Research Center in the School of Medicine at Columbia. He is also an affiliate faculty member of the Biomedical Engineering Program in the College of Engineering and Computing. 

Prior to joining the University of South Carolina, Dr. Evans received research funding from the British Heart Foundation, the British Society for Haematology, the University of Cambridge School of Biological Sciences, and the American Heart Association. His research is currently funded by the University of South Carolina School of Medicine, the American Heart Association, and the National Institute of General Medical Sciences. 

Dr. Evans serves on the Editorial Boards of Thrombosis Journal, Thrombosis Research, and Thrombosis Update. He is an Associate Editor of Frontiers in Cardiovascular Medicine and serves on the Early Career Editorial Board of Arteriosclerosis, Thrombosis, and Vascular Biology. He has obtained grant and travel support from more than 15 sources and has published more than 60 papers in peer-reviewed journals. 


2023: AHA’s Second Century Early Faculty Independence Award, American Heart Association, USA
2022: Research Leaders Academy, American Heart Association, USA
2022: Investigator Award, Santa Cruz Biotechnology, USA
2021: Travel Grant, ATVB Council, American Heart Association, USA
2021, 2022: Early Career Travel Award, International Society on Thrombosis and Haemostasis, USA
2020, 2021, 2022: Top Quartile Performance Award, Lurie Children’s Hospital of Chicago, USA
2019: Career Development Award, American Heart Association, USA
2016: Parke Davis Exchange Fellowship, University of Cambridge, UK
2015: Pump Priming Grant, British Heart Foundation, UK
2015: Early-Stage Start-Up Grant, British Society for Haematology, UK
2014: Junior Research Fellowship, Wolfson College, University of Cambridge, UK
2014: Associate Fellowship, Higher Education Academy, UK
2013: Travel Award, European Respiratory Society, NL
2012: Excellence in Science Award, American Association for the Advancement of Science, USA
2012: Young Investigator Award, Australasian Society of Thrombosis and Haemostasis, Australia
2012, 2014: Travel Fellowship, Thrombosis UK, UK
2008: Travel Grant, British Heart Foundation, UK
2007: Non-Clinical PhD Studentship, British Heart Foundation, UK
2006: Undergraduate Achievement Award, Physiological Society, UK

Research Overview

How do blood vessels respond when blocked or injured? Can this response be leveraged to treat inflammatory vascular diseases? The Evans Laboratory studies the vascular response to thrombosis with a view to improving treatments for inflammatory vascular diseases including acute respiratory distress syndrome.

Using clinically relevant disease models and targeted gene editing and drug delivery techniques, the lab focuses on two discrete but related disease areas: (i) thrombus formation and resolution; and (ii) inflammatory lung injury and repair. Upcoming studies will target thrombosis-induced metabolic signaling pathways that control endothelial survival and proliferation for the treatment of sepsis-induced lung injury.

The overall vision of the lab is to improve the understanding and treatment of inflammatory vascular diseases through translational studies of the vascular response to thrombosis. The lab is in a supportive and inclusive environment with emphasis on scientific excellence and professional development. Contact from prospective collaborators and lab members is welcome.

Challenge the conventional. Create the exceptional. No Limits.